Proactive Investors - Run By Investors For Investors

ICC International Cannabis agrees to buy Balkan Cannabis in deal adding to European operations

The purchase would give ICC access to Macedonian medical cannabis cultivation and extraction licenses as well as Bulgarian medical cannabis and hemp cultivation licenses
A marijuana plant
In 2017, the global medical cannabis industry was valued at US$15.6 billion

ICC International Cannabis Corp (CSE:WRLD) (OTCMKTS:KNHBF) said Friday that it has agreed to acquire all of Balkan Cannabis Corp in a deal adding to its medical cannabis and hemp production operations in Europe.

Vancouver-based ICC said in a press release that it’s buying a company that controls Macedonian medical cannabis cultivation and extraction licenses as well as Bulgarian medical cannabis and hemp cultivation licenses.

READ: ICC International Cannabis enters joint venture with Colombia-based Estrella Verde to expand offerings by more than 300 strains

Through a Macedonia subsidiary, Balkan Cannabis has been granted an exclusive agreement with a licensed facility permitting the cultivation, manufacturing and export of medical cannabis, according to ICC. The facility is located on 30 hectares (75 acres) in Valandovo, Macedonia.

The Balkan Cannabis subsidiary holds the only Macedonia extraction license to date and is building the country’s first dedicated industrial extraction facility, ICC said.

Balkan Cannabis owns 67% of the Macedonia subsidiary, with the rest controlled by a regional partner.

ICC added that Balkan Cannabis holds a 50% interest in a Bulgarian subsidiary that holds licenses for the production, manufacturing and export of hemp and medical Cannabis. Through the subsidiary, Balkan Cannabis controls 15,000 hectares (37,000 acres) with a two-year option to buy an additional 15,000 hectares.

Medical cannabis growth

In 2017, the global medical cannabis industry was valued at US$15.6 billion and is expected to expand at a compound annual growth rate of 17.7%, according to ICC, citing data from San Francisco-based Grand View Research

ICC advanced its global aspirations Thursday when it announced that it had entered a joint venture with Colombia-based Estrella Verde SAS, giving it access to more than 300 genetic cannabis strains.

 

Contact Dennis Fitzgerald at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full WRLD.U profile View Profile

ICC International Cannabis Corp. Timeline

Related Articles

cannabis plan in sun
February 21 2019
The cannabis company will manufacture, infuse and package branded recreational and wellness products
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use